All In MedTech

FDA Clearance Tracker · P080030-S021

iStent Trabecular Micro-Bypass Stent System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: May 29, 2018 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

May 29, 2018

Approved

Time to decision

89 days

Received Mar 1, 2018. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P080030-S021
Device name
iStent Trabecular Micro-Bypass Stent System
Applicant location
Laguna Hills, CA
Received
Mar 1, 2018
Decided
May 29, 2018
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P080030

Device type

Device class
Class III
Specialty
Ophthalmology

Every decision under product code OGO

FDA's approval statement

As written in FDA's record.

Approval for two alternate packaging configurations that include an ophthalmic clip.

Source documents

Other decisions for Glaukos Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

1 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.